We are monitoring the impact of COVID-19 on Europe Antifungal Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 214
Share on
Share on

Europe Antifungal Drugs Market Research Report – Segmented By Drug Type, Therapeutic Indications, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 214
Pages: 145

Europe Antifungal Drugs Market Size (2020 to 2025)

As per the report published, the Antifungal Drugs Market size in Europe USD 3.4 billion in 2020. It is projected to grow with a CAGR of 3.4% and worth USD 4.01 billion by 2025. In the following few years, the market is poised to grow hugely with the rising population globally.

Antifungal drugs are commonly used to cure fungal infections due to unclean, unhygienic, and damp environments. The invasion of epithelial tissue by microscopic organisms leads to fungal infections. Systemic fungal infections are caused due to indigestion or inhalation of spores, leading to fungal pneumonia, and diseases like candidiasis, meningitis, mucormycosis, etc., are caused by opportunistic fungus. Although most fungal infections and diseases are commonly non-lethal, they are very uncomfortable to the host, and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms by inhibiting cell wall formation, cell membrane disruption, and cell division.

The major factors driving the market are increasing awareness of fungal infections with the growing incidence rate of antifungal infections all over the world, increasing government and corporate funds in the industry. The development of public-private partnerships in the pharmaceutical industry and the rising popularity of over-the-counter antifungal drugs for dermal infections are vastly responsible for the growing antifungal drug market size. Also, the rising population with a weak immune system, in whom fungal infections are much more than average, will drive the market. The high prevalence of conventional drugs used for the treatment of fungal infections is significantly restraining market growth.

The cost of drugs and their effectiveness in treatments remain the challenges for the market.

This research report on the European Antifungal Drugs Market has been segmented and sub-segmented into the following categories:

By Drug Type: 

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

By Therapeutic Indications: 

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

By Application: 

  • Powders
  • Ointments
  • Drugs
  • Pastes

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Europe commands a second-largest share of the global antifungal drugs market next to North America. Germany contributes to the major share of the European antifungal drugs market. Growing technological advancements in the European region will drive the market.

Notable companies operating in the European Antifungal drugs market are Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead, and Abbott Laboratories.

1.Introduction                                  

            1.1 Market Definition                      

            1.2 Study Deliverables                     

            1.3 Base Currency, Base Year and Forecast Periods                    

            1.4 General Study Assumptions                

2. Research Methodology                           

            2.1 Introduction                   

            2.2 Research Phases            

                        2.2.1 Secondary Research   

                        2.2.2 Primary Research       

                        2.2.3 Econometric Modelling         

                        2.2.4 Expert Validation        

            2.3 Analysis Design              

            2.4 Study Timeline               

3. Overview                           

            3.1 Executive Summary                   

            3.2 Key Inferences                

            3.3 New Developments                   

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                        

            4.1 Market Drivers               

            4.2 Market Restraints                     

            4.3 Key Challenges               

            4.4 Current Opportunities in the Market             

5. Market Segmentation                             

            5.1 By Drug Type                  

                        5.1.1 Echinocandins 

                        5.1.2 Azoles  

                        5.1.3 Polyenes          

                        5.1.4 Allylamines     

                        5.1.5 Others  

            5.2 By Therapeutic Indications                   

                        5.2.1 Aspergillosis    

                        5.2.2 Dermatophytosis       

                        5.2.3 Candidiasis      

                        5.2.4 Others  

            5.3 By Application                

                        5.3.1 Powders          

                        5.3.2 Ointments       

                        5.3.5 Drugs   

                        5.3.4 Pastes  

6. Geographical Analysis                             

            6.1 Europe                

                        6.1.1 Introduction    

                        6.1.2 U.K       

                        6.1.3 Spain    

                        6.1.4 Germany         

                        6.1.5 Italy      

                        6.1.6 France            

7.Strategic Analysis                         

            7.1 PESTLE analysis              

                        7.1.1 Political

                        7.1.2 Economic         

                        7.1.3 Social   

                        7.1.4 Technological  

                        7.1.5 Legal     

                        7.1.6 Environmental

            7.2 Porter’s Five analysis                

                        7.2.1 Bargaining Power of Suppliers          

                        7.2.2 Bargaining Power of Consumers      

                        7.2.3 Threat of New Entrants         

                        7.2.4 Threat of Substitute Products and Services

                        7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                         

            8.1 Alternaria                       

                        8.1.1 Overview         

                        8.1.2 Product Analysis        

                        8.1.3 Strategic Evaluation and Operations           

                        8.1.4 Financial analysis       

                        8.1.5 Legal issues     

                        8.1.6 Recent Developments

                        8.1.7 SWOT analysis

                        8.1.8 Analyst View   

            8.2 Pfizer                   

            8.3 Novartis              

            8.4 Sanofi-Aventis                

            8.5 Merck & Co.                   

            8.6 Asperqillus                     

            8.7 Kramer Laboratories                 

            8.8 Bayer Healthcare                       

            8.9 Enzon Pharmaceuticals             

            8.10 Glaxosmithkline Gilead                      

            8.11 Abbott Laboratories               

9.Competitive Landscape                            

            9.1 Market share analysis               

            9.2 Merger and Acquisition Analysis                     

            9.3 Agreements, collaborations and Joint Ventures                   

            9.4 New Product Launches             

10.Expert Opinions                          

            10.1 Market Outlook                       

            10.2 Investment Opportunities                 

Appendix                               

            a) List of Tables                    

               b) List of Figures       

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. North America Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  2. North America Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Billion)
  3. North America Echinocandins Market, By Region, From 2020 to 2025 (USD Billion)
  4. North America Azoles Market, By Region, From 2020 to 2025 (USD Billion)
  5. North America Polyenes Market, By Region, From 2020 to 2025 (USD Billion)
  6. North America Allylamines Market, By Region, From 2020 to 2025 (USD Billion)
  7. North America Other Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  8. North America Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Billion)
  9. North America Aspergillosis Market, By Region, From 2020 to 2025 (USD Billion)
  10. North America Dermatophytosis Market, By Region, From 2020 to 2025 (USD Billion)
  11. North America Candidiasis Market, By Region, From 2020 to 2025 (USD Billion)
  12. North America Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Billion)
  13. North America Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Billion)
  14. North America Powders Market, By Region, From 2020 to 2025 (USD Billion)
  15. North America Ointments Market, By Region, From 2020 to 2025 (USD Billion)
  16. North America Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  17. North America Pastes Market, By Region, From 2020 to 2025 (USD Billion)
  18. United States Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Billion)
  19. United States Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Billion)
  20. United States Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Billion)
  21. Canada Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Billion)
  22. Canada Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Billion)
  23. Canada Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Billion)
  24. a Europe Antifungal Drugs Market, By Region, From 2020 to 2025 (USD Million)
  25. Europe Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  26. Europe Echinocandins Market, By Region, From 2020 to 2025 (USD Million)
  27. Europe Azoles Market, By Region, From 2020 to 2025 (USD Million)
  28. Europe Polyenes Market, By Region, From 2020 to 2025 (USD Million)
  29. Europe Allylamines Market, By Region, From 2020 to 2025 (USD Million)
  30. Europe Other Drugs Market, By Region, From 2020 to 2025 (USD Million)
  31. Europe Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  32. Europe Aspergillosis Market, By Region, From 2020 to 2025 (USD Million)
  33. Europe Dermatophytosis Market, By Region, From 2020 to 2025 (USD Million)
  34. Europe Candidiasis Market, By Region, From 2020 to 2025 (USD Million)
  35. Europe Other Therapeutic Indications Market, By Region, From 2020 to 2025 (USD Million)
  36. Europe Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  37. Europe Powders Market, By Region, From 2020 to 2025 (USD Million)
  38. Europe Ointments Market, By Region, From 2020 to 2025 (USD Million)
  39. Europe Drugs Market, By Region, From 2020 to 2025 (USD Million)
  40. Europe Pastes Market, By Region, From 2020 to 2025 (USD Million)
  41. U.K Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  42. U.K Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  43. U.K Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  44. Spain Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  45. Spain Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  46. Spain Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  47. Germany Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  48. Germany Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  49. Germany Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  50. Italy Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  51. Italy Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  52. Italy Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)
  53. France Antifungal Drugs Market, By Drug Type, From 2020 to 2025 (USD Million)
  54. France Antifungal Drugs Market, By Therapeutic Indications, From 2020 to 2025 (USD Million)
  55. France Antifungal Drugs Market, By Application, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample